Suraksha Diagnostic Limited Announces Unaudited Financial Results for Q2 and H1 Ending September 30, 2026
Board approved standalone and consolidated financial results; limited review report issued by statutory auditors
Suraksha Diagnostic Limited has released its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, along with the limited review report by statutory auditors as per SEBI Listing Regulations.
Suraksha Diagnostic Limited
Financial Results
Suraksha Diagnostic Limited has approved its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, accompanied by a limited review report from the statutory auditors.
The Board of Directors met on November 10, 2026, and considered the unaudited financial results for both standalone and consolidated accounts for Q2 and H1 period of the fiscal year ending September 30, 2026.
These financial results have been subjected to a limited review by the Company's statutory auditors as required under SEBI Listing Regulations.
The company has made these results available on its website www.surakshanet.com for wider accessibility to investors and stakeholders.
The Board meeting began at 3:00 PM IST and concluded at 3:40 PM IST on the same day.
Highlights
- Unaudited financial results for Q2 and H1 ended September 30, 2026 approved by the Board.
- Results cover both standalone and consolidated financial statements.
- Limited review report issued by statutory auditors accompanies the results.
- Results available on Suraksha Diagnostic Limited's official website.
- Board meeting held on November 10, 2026, lasted 40 minutes.
Key Data Snapshot
What happened
- Suraksha Diagnostic Limited's Board of Directors approved the unaudited financial results for the quarter and half year ended September 30, 2026.
- The approval covers both standalone and consolidated financial statements.
- The meeting took place on November 10, 2026, and lasted 40 minutes.
Key details
- Results accompanied by a Limited Review Report issued by the statutory auditors as per SEBI Listing Regulations.
- Results have been uploaded to the company’s official website for public access.
- The company follows SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
Regulatory and governance context
- Announcement made under Regulation 30 and Regulation 33 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
- Intimation includes Part A of Schedule III, ensuring compliance with disclosure norms.
Highlights
- Unaudited financial results for Q2 and H1 ended September 30, 2026 approved by the Board.
- Results cover both standalone and consolidated financial statements.
- Limited review report issued by statutory auditors accompanies the results.
- Results available on Suraksha Diagnostic Limited's official website.
- Board meeting held on November 10, 2026, lasted 40 minutes.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Kaynes Technology India Limited Reports Q2 FY2027 Un-audited Results and Enters Joint Venture to Produce TFT Modules
Kaynes Technology India Limited released its un-audited financial results for the quarter and half year ended September 30, 2026, and approved a joint venture with Toyokawa Techno Private Limited to produce Thin-Film Transistor Display Modules in India, while proposing voluntary strike-off of a subsidiary.
Read Full StoryITI Limited Reports ₹49,528 Lakh Revenue and ₹6,368 Lakh Consolidated Loss Before Tax for Half Year Ending September 2026
ITI Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended 30th September 2026, revealing total consolidated revenue of ₹49,528 lakh for the quarter and a consolidated loss before tax of ₹6,368 lakh for the half-year period.
Read Full StoryZetwerk Manufacturing Businesses Limited Reports Q2 FY2027 Loss with Rs. 886.06 Million Receivables Dispute, Appoints New Company Secretary
Zetwerk Manufacturing Businesses Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, reporting a loss before tax of Rs. 1,193.17 million for the quarter. The company highlighted ongoing litigation over receivables totaling Rs. 886.06 million, alongside key administrative updates.
Read Full Story